# A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)

> **NCT03086460** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 67 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CHF 1531 pMDI
- **DRUG:** Formoterol Inhalation Solution
- **DRUG:** Placebo pMDI

## Key facts

- **NCT ID:** NCT03086460
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-08
- **Primary completion:** 2018-07-23
- **Final completion:** 2018-07-28
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2021-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086460, "A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT03086460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*